questionText: To ask the Secretary of State for Health and Social Care, whether she plans to return to 12 months average timescales for the licensing of generic and biosimilar medicines.
answerText: The Medicines and Healthcare products Regulatory Agency (MHRA) has taken urgent action to deliver improvements to decision timescales in established medicines. The timely processing of marketing authorisation applications to ensure continued access to med...
heading: Drugs: Licensing